Edition:
United States

People: AstraZeneca PLC (AZN.L)

AZN.L on London Stock Exchange

5,002.00GBp
12:14pm EDT
Change (% chg)

47.00p (+0.95%)
Prev Close
4,955.00p
Open
4,962.00p
Day's High
5,010.00p
Day's Low
4,962.00p
Volume
2,342,503
Avg. Vol
2,757,098
52-wk High
5,505.00p
52-wk Low
3,680.00p

Hudson, Paul 

Mr. Paul Hudson is President, AstraZeneca, US and Executive Vice-President, North America., since January 2013 and leads AstraZeneca’s commercial operations in North America. In this capacity, he is accountable for driving growth and maximising the contribution of North America to AstraZeneca’s global business. Paul joined AstraZeneca in 2006 as Vice-President and Primary Care Director, UK and was later appointed President of AstraZeneca K. K., AstraZeneca’s Japanese subsidiary, and President of AstraZeneca’s business in Spain. He has served as a Standing Board Member of the Japan Pharmaceuticals Manufacturers Association and EFPIA in Japan. Before joining AstraZeneca, Paul worked for Schering-Plough, where he held senior global marketing roles. He received a degree in economics from Manchester Metropolitan University and a DipM from the UK’s Chartered Institute of Marketing.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --